Saturday, 17 October 2026European Markets
ExploreSearch
ViaNews EU
stockMarket

TEKNA HOLDING Stock Is 31% Up In The Last 21 Sessions

Loading stream...

(VIANEWS) - Shares of TEKNA HOLDING (Oslo Børs All-share Index_GI: TEKNA.OL) rose by a staggering 31.58% in 21 sessions from 5.7 kr to 7.50 kr at 04:46 EST on Friday, following the last session's upward trend. Oslo Børs All-share Index_GI is falling 0.2% to 1,413.04 kr, after three sequential sessions in a row of losses.

About TEKNA HOLDING

Tekna Holding ASA develops, manufactures, and sells micro and nano powders, and plasma process solutions in North America, Europe, and Asia. Its material powders and plasma systems are used in various industrial sectors, such as aviation, aerospace, medical, mining and drilling, energy storage, and microelectronics; and applications, such as additive manufacturing, metal injection molding, thermal spray, and hot isostatic pressing. The company was founded in 1990 and is headquartered in Sherbrooke, Canada. Tekna Holding ASA is a subsidiary of Arendals Fossekompani ASA.

Volume

Today's last reported volume for TEKNA HOLDING is 95885 which is 7.7% above its average volume of 89025.

More news about TEKNA HOLDING (TEKNA.OL).

Categories

stockMarket

Tags

Stock PriceMarket Session NowStock Market NowPrice UpTEKNA.OLMarket SessionStock Price UpStock MarketTEKNA HOLDINGStock
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,384 source documents archived
Query this data → isubstrate.com